Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
St. Vincent Mercy Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Medical University of Ohio Cancer Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated:  9/18/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
Status: Enrolling
Updated: 9/18/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/18/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/18/2015
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
Allegiance Health
mi
from
Jackson, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
McLaren Greater Lansing
mi
from
Lansing, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
McLaren Greater Lansing
mi
from
Lansing, MI
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
Sparrow Cancer Center
mi
from
Lansing, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
Sparrow Cancer Center
mi
from
Lansing, MI
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
McLaren Macomb
mi
from
Mount Clemens, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
McLaren Macomb
mi
from
Mount Clemens, MI
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
McLaren Central Michigan
mi
from
Mount Pleseant, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
McLaren Central Michigan
mi
from
Mount Pleseant, MI
Click here to add this to my saved trials
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated:  9/18/2015
St Joseph Mercy Oakland Hospital
mi
from
Pontiac, MI
Saw Palmetto: Symptom Management for Men During Radiation Therapy
Saw Palmetto Use During Radiation Therapy for Symptom Management Among Prostate Cancer Patients
Status: Enrolling
Updated: 9/18/2015
St Joseph Mercy Oakland Hospital
mi
from
Pontiac, MI
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
University of Miami Hospitals & Clinics/ Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
University of Miami Hospitals & Clinics/ Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
Associates in Oncology and Hematology
mi
from
Chattanooga, TN
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
Associates in Oncology and Hematology
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
The West Clinic, PC
mi
from
Memphis, TN
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated:  9/18/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line Treatment for Patients With Advanced Biliary Cancer
Status: Enrolling
Updated: 9/18/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated:  9/18/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated: 9/18/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated:  9/18/2015
Tennessee Oncology PLLC
mi
from
Chattanooga, TN
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated: 9/18/2015
Tennessee Oncology PLLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated:  9/18/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated: 9/18/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated:  9/18/2015
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated: 9/18/2015
The Center for Cancer and Blood Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated:  9/18/2015
Virginia Cancer Institute
mi
from
Richmond, VA
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
A 2-Part Phase 2 Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy
Status: Enrolling
Updated: 9/18/2015
Virginia Cancer Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Providence Cancer Center
mi
from
Mobile, AL
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Providence Cancer Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Washington Regional Medical Center
mi
from
Fayetteville, AR
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Washington Regional Medical Center
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
St. Vincent Doctors Doctors Hospital
mi
from
Little Rock, AR
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
St. Vincent Doctors Doctors Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Baptist Health Medical Center
mi
from
Little Rock, AR
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Baptist Health Medical Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Mercy San Juan Hospital
mi
from
Carmichael, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Mercy San Juan Hospital
mi
from
Carmichael, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Arrowhead Regional Medical Center
mi
from
Colton, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Arrowhead Regional Medical Center
mi
from
Colton, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Mount Diablo Regional Cancer Center
mi
from
Concord, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Mount Diablo Regional Cancer Center
mi
from
Concord, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Loma Linda University Cancer Institute at Loma Linda University Medical Center
mi
from
Loma Linda, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Loma Linda University Cancer Institute at Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Summit Medical Center
mi
from
Oakland, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Summit Medical Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
St. Joseph Hospital Regional Cancer Center - Orange
mi
from
Orange, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
St. Joseph Hospital Regional Cancer Center - Orange
mi
from
Orange, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Palo Alto Medical Foundation
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Huntington Cancer Center at Huntington Hospital
mi
from
Pasadena, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Huntington Cancer Center at Huntington Hospital
mi
from
Pasadena, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Shasta Regional Medical Center
mi
from
Redding, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Shasta Regional Medical Center
mi
from
Redding, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
John Wayne Cancer Institute at Saint John's Health Center
mi
from
Santa Monica, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
John Wayne Cancer Institute at Saint John's Health Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
Sonoma Valley Hospital
mi
from
Sonoma, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
Sonoma Valley Hospital
mi
from
Sonoma, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated:  9/18/2015
St. Joseph's Regional Cancer Center
mi
from
Stockton, CA
Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Status: Enrolling
Updated: 9/18/2015
St. Joseph's Regional Cancer Center
mi
from
Stockton, CA
Click here to add this to my saved trials